Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	19	20	10	13	-	-	Upgrade
Market Cap Growth	103.95%	103.95%	-23.60%	-	-	-	Upgrade
Enterprise Value	24	22	13	12	-	-	Upgrade
Last Close Price	2.98	3.10	1.52	2.00	-	-	Upgrade
PE Ratio	-	-	40.17	18.82	-	-	Upgrade
Forward PE	9.51	11.89	10.74	8.60	-	-	Upgrade
PS Ratio	0.94	0.98	0.82	1.01	-	-	Upgrade
PB Ratio	2.60	2.71	1.30	1.87	-	-	Upgrade
P/TBV Ratio	3.01	3.13	1.41	1.92	-	-	Upgrade
P/OCF Ratio	37.88	39.41	-	-	-	-	Upgrade
PEG Ratio	-	0.48	0.48	0.27	-	-	Upgrade
EV/Sales Ratio	1.20	1.10	1.12	0.99	-	-	Upgrade
EV/EBITDA Ratio	31.65	29.03	21.09	17.36	-	-	Upgrade
EV/EBIT Ratio	117.04	107.37	35.59	27.65	-	-	Upgrade
Debt / Equity Ratio	0.76	0.76	0.53	0.38	1.04	1.51	Upgrade
Debt / EBITDA Ratio	7.27	7.27	6.28	3.58	1.38	27.14	Upgrade
Asset Turnover	1.06	1.06	0.73	1.09	1.58	1.00	Upgrade
Inventory Turnover	1.86	1.86	1.36	2.61	3.11	1.70	Upgrade
Quick Ratio	0.78	0.78	0.87	1.23	0.86	1.13	Upgrade
Current Ratio	1.75	1.75	1.89	1.98	1.53	2.57	Upgrade
Return on Equity (ROE)	-1.71%	-1.71%	3.39%	14.32%	63.39%	-0.35%	Upgrade
Return on Assets (ROA)	0.68%	0.68%	1.43%	2.45%	16.61%	0.43%	Upgrade
Return on Capital (ROIC)	1.07%	1.07%	2.24%	3.81%	25.83%	0.72%	Upgrade
Return on Capital Employed (ROCE)	2.00%	2.00%	4.10%	5.70%	48.50%	0.90%	Upgrade
Earnings Yield	-0.66%	-0.64%	2.49%	5.31%	-	-	Upgrade
FCF Yield	-1.70%	-1.63%	-8.98%	-27.05%	-	-	Upgrade

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.